Perspectives on the Systemic Staging in Newly Diagnosed Breast Cancer

Clin Breast Cancer. 2021 Mar 27:S1526-8209(21)00065-3. doi: 10.1016/j.clbc.2021.03.010. Online ahead of print.ABSTRACTBreast cancer is a complex disease, and accurate systemic staging is an essential aspect of the evaluation of a patient with newly diagnosed breast cancer. Considering that the chance of having metastatic disease at breast cancer diagnosis is different in each patient and depends on a variety of anatomic and biologic factors, it is crucial to understand that some populations may benefit from more intensive staging because their pretest probability of metastatic disease is higher than that of the average patient. Identifying these patients with de novo stage IV breast cancer is associated with substantial prognostic and therapeutic implications. Unfortunately, recent advances in understanding breast cancer heterogeneity and molecular biology have not been incorporated in the international guidelines and recommendations about imaging examinations for detecting de novo metastatic breast cancer. This review article discusses important issues regarding the rationale for performing systemic staging, addresses current and innovative imaging methods, and proposes an algorithm for systemic staging in patients with newly diagnosed breast cancer.PMID:33962905 | DOI:10.1016/j.clbc.2021.03.010
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Source Type: research